Our latest review article, from Jonny Gillan, together with Robert Gray, is now out in the European Respiratory Journal

link to paper

This review discusses the merits of targeting inflammation in cystic fibrosis, in the context of the success of the new CFTR modulator therapies, with a special focus on macrophages.